Skip to main content
. 2020 Jun 30;2020:5120230. doi: 10.1155/2020/5120230

Figure 9.

Figure 9

The novel THA-adamantanamines 26 and 27 acting as ChE inhibitors and NMDAR antagonists. Also, tacripyrimidines with general structure 28 are here represented as agents influencing Ca2+ influx and intracellular concentration by blocking voltage-gated Ca2+ channels.